Cairo Unoversity
Giza, Egypt
Location status: Recruiting
Location contact
Ali Ismail, lecturer
CONTACT
ramy, draz
CONTACT
NCT Number: NCT06803108
exercise is very important maneuver in the control of elevated liver enzymes in complaint of fatty liver .. the exercise forma are many.. from these exercises, pyramidal training or continues aerobic one.
Interested in participating?
Request Info37 year–51 year
Female
Interventional
Not applicable
Giza, Egypt
Location status: Recruiting
Ali Ismail, lecturer
CONTACT
ramy, draz
CONTACT
the total participating subjects of the two groups of this study will be fatty liver subjects (19 subjects in every group). aerobic training on electronic treadmill will be adopted for 60 minutes in one group. In the other group, a pyramidal training will be adopted for nearly 60 minutes (nearly two rounds of 21 minutes of running on electronic treadmill will be separated with 10 minutes of rest between the two rounds. Also, warming (4 minutes before start of pyrimidal trianing) and cooling (4 minutes after pyramidal training) will be done through gentle stretching exercises/activities. the both forms of exercises will be done three times per week. the total study time will be 12 weeks. to be mentioned , the two groups followed low clorie diet
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
the participating subjects of this group of this study will be fatty liver subjects (19 subjects in this group). aerobic training on electronic treadmill will be adopted for 60 minutes in one group. In this group, a pyramidal training will be adopted for nearly 60 minutes (nearly two rounds of 21 minutes of running on electronic treadmill will be separated with 10 minutes of rest between the two rounds. Also, warming (4 minutes before start of pyrimidal trianing) and cooling (4 minutes after pyramidal training) will be done through gentle stretching exercises/activities. this form form of exercise will be done three times per week. the total study time will be 12 weeks. to be mentioned, the this group will follow low clorie diet
the participating subjects of the this group of this study will be fatty liver subjects (19 subjects in this group). aerobic training on electronic treadmill will be adopted for 60 minutes in this group with moderate intensity. the form of exercise will be done three times per week. the total study time will be 12 weeks. to be mentioned , this group will follow low clorie diet
Time frame: it will be measured after 12 weeks
it is a liver enzyme
Time frame: it will be measured after 12 weeks
it is a liver enzyme
Time frame: it will be measured after 12 weeks
it is a liver enzyme
Time frame: it will be measured after 12 weeks
it is a liver enzyme
Time frame: it will be measured after 12 weeks
it will measured in serum
Time frame: it will be measured after 12 weeks
it will measured in serum
Time frame: It will be measured after 12 weeks
it will be measured on empty stomach
Time frame: It will be measured after 12 weeks
it will be measured at level of umbilicus
Contact information is provided by the study sponsor or research team.
Ali MA Ismail, lecturer
CONTACT
ramy draz, lecturer
CONTACT
Cairo University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07221188
Digestive System Diseases, Fatty Liver
Arcadia, California, United States
View Trial DetailsNCT03884075
Digestive System Diseases, Fatty Liver
Bethesda, Maryland, United States
View Trial DetailsNCT07403604
Body Weight, Diabetes Mellitus
New York, United States
View Trial DetailsNCT06138821
Body Weight, Body Weight Changes
Boston, Massachusetts, United States
View Trial Details